Latest News in Biostatistics

Across Yale University, students and faculty are left grappling with the afterlife of eugenics and considering how this history should be addressed in the science curriculum.

A team of Yale-led researchers can now quantify the factors causing changes in the DNA that contribute most to cancer growth in tumors of most major tumor types. Their molecular analysis approach brings clarity to a longstanding debate over how much control humans have over developing cancer over time.

Cancer results from a combination of spontaneous mutations that arise with age—just call it “bad luck”—and environmental exposures to carcinogens such as tobacco, ultraviolet light or viruses. But the question of the relative contribution of luck—compared with more explicit causes—has generated vigorous debate for years.

BOSTON – ‘Ancient Greek Cuisine: Back to the Future’ is the title of the symposium that will take place on April 19 and 20 at Yale University, which is expected to be packed with hundreds of guests. A symposium inspired by Greek antiquity and myth.

Scientists are exploring a theory suggesting that exposure to one respiratory virus helps the body fend off competing pathogens.

Yale School of Public Health and Center for Methods in Implementation and Prevention Science (CMIPS) faculty member Fan Li, PhD, has been invited to serve on the editorial board for the journal Implementation Science. Dr. Li is an Assistant Professor in the Department of Biostatistics at the Yale School of Public Health and is the recipient of a recent Patient-Centered Outcome Research Institute grant for his work on developing methods and software to plan pragmatic cluster randomized trials.

We as humans differ from one another in our backgrounds, genetics, and health conditions. For instance, most of us are aware that no two people are the same based on our genetic makeup and lived experiences. Yet clinical trials are often not designed to powerfully analyze how various individual differences like age, health history, and socioeconomic status impact the effect of specific interventions. Fan Li, PhD, Assistant Professor of Biostatistics and faculty member at the Center for Methods in Implementation and Prevention Science (CMIPS) at the Yale School of Public Health, has recently received an award from the Patient-Centered Outcomes Research Institute (PCORI) to develop new methods for planning cluster randomized trials that will incorporate such factors into relevant research and interventions.

Public health experts are getting a better picture of drug-resistant tuberculosis in Moldova, thanks to the efforts of a coalition of researchers from across the world led by scientists at the Yale School of Public Health.

A new study by Yale researchers finds that, due to structural racism, the populations most at risk for contracting and dying from COVID-19 — Black, Indigenous, and LatinX populations— had less access to COVID-19 testing centers.